Percutaneous Cryo May Offer Benefits
Percutaneous renal cryoablation (PERC) for select tumors is comparable to laparoscopic renal cryoablation (LAP) with respect to short-term outcomes and complications, data suggest.
Kidney Cancer
Sorafenib Benefit Unaffected by Prior Cytokine Therapy
Sorafenib treatment doubles progression-free survival in patients with advanced renal cell carcinoma, regardless of whether they have received prior cytokine therapy.
Stereotactic Radiosurgery Beneficial
SAN DIEGO—Stereotactic radiosurgery produces early and durable responses in renal cell carcinoma (RCC) patients with either previously untreated spinal metastases or spinal metastases that have recurred after prior radiotherapy, researchers announced here at the 2007 Annual Meeting of the American Academy of Orthopedic Surgeons.
First-Line RCC Treatment Cleared in Sunitinib Labeling
New labeling of Sutent (sunitinib malate, Pfizer) has been approved that includes first-line treatment of advanced renal cell carcinoma (RCC).
FDA Strengthens ESA Safety Information
The FDA issued a public health advisory outlining new safety information, including revised product labeling about erythropoiesis-stimulating agents (ESAs). The drugs affected by the safety update are darbepoetin alfa (Aranesp) and epoetin alfa (Epogen and Procrit).
Laparoscopic Nephrectomies Safe Despite Comorbidities
Laparocopic nephrectomy can be performed safely and effectively in patients with three or more comorbidities, a Japanese study shows.
Laparoscopic Nephrectomy Effective for Large Tumors
Large renal tumors can be removed safely and effectively with laparoscopic nephrectomy (LN), a study shows.
Partial Nephrectomy for RCC Has Excellent 15-Year Results
Partial nephrectomy for renal cell carcinoma provides excellent long-term disease-specific survival, researchers say.
Drugs Aid Metastatic RCC Outcomes
Two relatively new oral agents can improve outcomes for patients with metastatic renal cell carcinoma (RCC), according to recent reports. The drugs, sunitinib and sorafenib, inhibit enzymes that promote angiogenesis and thus may act by disrupting tumor vasculature.
Simple Enucleation for Small RCC Tumors Safe, Acceptable
Simple enucleation is a safe and acceptable nephron-sparing treatment for pT1a renal cell carcinoma (RCC), Italian researchers say.
-
Loading...
-
Loading...
